Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Abstract Neurodegenerative diseases are a growing burden, and there is an urgent need for better biomarkers for diagnosis, prognosis, and treatment efficacy. Structural and functional brain alterations are reflected in the protein composition of cerebrospinal fluid (CSF). Alzheimer's disease (A...
Saved in:
| Main Authors: | Jakob M Bader, Philipp E Geyer, Johannes B Müller, Maximilian T Strauss, Manja Koch, Frank Leypoldt, Peter Koertvelyessy, Daniel Bittner, Carola G Schipke, Enise I Incesoy, Oliver Peters, Nikolaus Deigendesch, Mikael Simons, Majken K Jensen, Henrik Zetterberg, Matthias Mann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2020-06-01
|
| Series: | Molecular Systems Biology |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/msb.20199356 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
“Proteinjury”: a universal pathological mechanism mediated by cerebrospinal fluid in neurodegeneration and trauma
by: Vladimir F. Lazarev, et al.
Published: (2025-05-01) -
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2016-08-01) -
Cerebrospinal Fluid Analysis in Infectious Disease
by: Tapisha Gupta
Published: (2022-06-01) -
Proteomic analysis reveals candidate molecules to mediate cortical pathology and identify possible biomarkers in an animal model of multiple sclerosis
by: Berenice Anabel Silva, et al.
Published: (2025-02-01) -
The genetic regulation of protein expression in cerebrospinal fluid
by: Oskar Hansson, et al.
Published: (2022-12-01)